1. Home
  2. SKIL vs NSRX Comparison

SKIL vs NSRX Comparison

Compare SKIL & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Skillsoft Corp.

SKIL

Skillsoft Corp.

N/A

Current Price

$6.01

Market Cap

40.2M

Sector

Technology

ML Signal

N/A

Logo Nasus Pharma Ltd. Ordinary Shares

NSRX

Nasus Pharma Ltd. Ordinary Shares

N/A

Current Price

$3.54

Market Cap

38.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SKIL
NSRX
Founded
1998
2019
Country
United States
Israel
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
40.2M
38.9M
IPO Year
2019
2024

Fundamental Metrics

Financial Performance
Metric
SKIL
NSRX
Price
$6.01
$3.54
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $19.67
AVG Volume (30 Days)
★ 95.4K
14.2K
Earning Date
04-07-2026
03-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
$0.11
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.43
$1.98
52 Week High
$18.45
$9.50

Technical Indicators

Market Signals
Indicator
SKIL
NSRX
Relative Strength Index (RSI) 46.11 53.03
Support Level $5.06 $2.97
Resistance Level $8.40 $4.49
Average True Range (ATR) 0.62 0.25
MACD 0.08 -0.00
Stochastic Oscillator 61.39 79.69

Price Performance

Historical Comparison
SKIL
NSRX

About SKIL Skillsoft Corp.

Skillsoft Corp is a leader in corporate digital learning. The company's segments include Talent Development Solutions and Global Knowledge. Talent Development Solutions brings a foundation of products and customers. TDS enterprise-grade solution serves customers and employees world-wide. TDS Learner is a world-renowned consumer-scale and experiential learning platform that serves learners internationally. The Global Knowledge segment is centered around instructor-led training, or live learning, with face-to-face delivery by experienced trainers, both in-person and virtually.

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Share on Social Networks: